Search PubMed⌕ Search

Biomedical subjects

A Wischnik

Publications and source records attributed to A Wischnik.

At least 37 records · Page 2Linked to original sources
PubMed1993

[Endoscopy of the preperitoneal interstitium--a new approach for colposuspension].

The successful use of fibrin sealant in Colposuspensive surgery has been proved in long-term follow-up studies, avoiding disadvantages and risk of the suture technique. We introduce a new technique allowing us to perform colposuspension by minimal invasive surgery. By endoscopic approach of the pre-peritoneal interstice (Retziiscopy), a correct preparation of urinary bladder, urethra, vaginal fascia and Cavum Retzii is possible. Following preparation, colposuspension by means of fibrin sealant can be performed.

Female↗
PubMed1992

[Fetal outcome of premature infants less than 1,500 g birth weight with special reference to surfactant requirements].

The objective of our study was to examine therapeutic success within a study group of 108 premature babies weighing less than 1500 g at birth. The foetal outcome was divided according to intrauterine betamethasone administration, method of birth and surfactant requirement. 59 of the babies did not require a surfactant factor, because within 12 hours it was possible, to reduce respiration to an O2 partial pressure of 20%. In 49 of the premature babies, this was not possible, and therefore, surfactant substitution was required, whereby this subject group was divided into surfactant responders and surfactant non-responders. In addition, we examined the influence of the method of birth on later survival and the occurrence of intraventricular haemorrhages in the children. A noticeably higher survival rate was determined in 81% of the children, born via Caesarean section, compared with 63% of premature babies, born via vaginal delivery. Likewise, detectable intraventricular haemorrhages (IVH) were significantly lower amongst premature babies delivered via Caesarean section (25%) than those delivered vaginally (37.5%). A considerable improvement in survival rates and a reduction in IVH was achieved by means of completed lung maturation with betamethasone (16 mg in 48 hours). 62% of premature infants with completed prepartal lung maturity did not require the administration of a surfactant due to the favourable respiratory situation. However, for those cases, where it was no longer possible to conduct lung maturation, only 46% did not require surfactant substitution. Therefore, it would appear advisable, to delay the delivery of premature babies weighing less than 1500 g in order to carry out lung maturity treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Actuarial Analysis↗
PubMed1992

[Struma carcinoid tumor within a dermoid cyst as an incidental finding in cesarean section].

A 25-year-old primigravida with breech presentation was admitted near term. During Caesarean section, a dermoid cyst of the right ovary was detected. The dermoid cyst was enucleated, preserving a plum-sized ovary. Histology revealed a strumal carcinoid within the excised dermoid cyst. From the histological point of view it was classified as a tumour of low malignancy. The clinical study provided no evidence of any metastases. On the 14th postoperative day the patient could be discharged from hospital subject to close aftercare control.

Adult↗
PubMed1992

[Do the obstetrically relevant bony pelvic measurements change? A retrospective analysis of computed tomographic pelvic x-rays].

The important dimensions of pelvimetry were evaluated from 467 CT studies of the pelvis by trigonometric deduction. The age of the women was between 18 and 88 years. In addition to the diameters, which are routinely used for pelvimetry, transverse and sagittal diameters, pelvic angles and areas of pelvic planes were calculated. On condition that the pelvic dimensions do not depend on age the parameters can be regarded as representative of sexual maturity. 5 parameters showed highly significant and 7 parameters showed significant differences between the age-classes 1901-1920 and 1950-1971. An increase of pelvic dimensions (1950-1971) was found at the planes of the pelvic inlet and outlet in contrast to the dimensions of the pelvic center. The results confirm the importance of the bispinous diameter for pelvimetry as well as the demand for a revision of the standard values of the first half of the century.

Adolescent↗
PubMed1992

[Magnetic resonance tomography as the basis for biomechanical analysis. The simulation of the birth process as an example of the expanded information potentials of segmental imaging procedures].

A method is presented that enables the use of (static) informations from magnetic resonance imaging (MRI) for (dynamic) biomechanical analysis. Using a specially developed software MRI pixel matrices are colour-coded and--according to the principle of same density--line data are created. After sectional attribution of the resulting polygons a three-dimensional mesh of so-called finite elements is created which can then be used in deformation analysis. This method is exemplified by a project dealing with the simulation of birth mechanics, which is finally aimed at validating the results from radiologic pelvimetry. First analyses show that even under foetal head moulding conditions, being considered as normal, such sensitive structures as the cerebellum, brain stem as well as the ventricles with the plexus chorioidei are to be found within the maximum isobars within a range of 104-140 N(10.6-14.3 kp).

Adult↗
PubMed1989

The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.

We have studied the transfer of the analgesic ketorolac tromethamine into breast milk in ten women aged between 22 and 35 years. Ketorolac administration was started between 2 and 6 days after delivery. The breast milk was not fed to the infant because of maternal antibiotic use (6 patients) or because of jaundice of the baby. 10 mg of ketorolac was given four times daily for two days. Plasma and milk samples were collected on the two dosing days and on the first day after dosing. The plasma and milk were assayed for ketorolac concentrations by HPLC: the quantification limits were 10 ng.ml-1 and 5 ng.ml-1 respectively. The maternal plasma concentrations were within established ranges for ketorolac. In four patients the concentration of ketorolac in the milk was never above 5 ng.ml-1. At 2 h after dosing on both Days 1 and 2 there were quantifiable concentrations of ketorolac in the milk. The range was 5.2 ng.ml-1 to 7.9 ng.ml-1. The ratio of breast milk: plasma concentrations of ketorolac ranged from 0.015 to 0.037. The maximum potential amount of ketorolac that an infant may be exposed to daily could range from 3.16 mg to 7.9 mg, assuming a consumption of between 400 ml and 1 l of breast milk. On a weight-adjusted basis this is equivalent to between 0.16% and 0.40% of the total daily maternal dose.

Administration, Oral↗
PubMed1989

[The "other induction"--experiences and consequences in 281 deliveries following intravaginal administration of PGE2 tablets].

186 patients have been included prospectively in a study, aimed at analysing the course of birth after induction with 3 mg PGE2-tablets given intravaginally. These data are compared with those gained from a retrospective analysis of 95 patients using a dose of 2 mg. The total of the births within our clinic in 1986/87 functions as controls. Although in every case there has been an urgent need for the termination of pregnancy and there have been also unfavourable cervix findings in the 3 mg group, no differences could be observed in comparison to the control group concerning duration of cervical dilatation and expulsion, as well as foetal outcome parameters. When comparing the 2 mg and 3 mg groups, a certain superiority of the 3 mg dosage could be noted, leading to the opinion, that trial dosages of less than 3 mg should be abandoned. C-section rate was lowest and spontaneous birth rate was highest in the 3 mg group as compared to the 2 mg and the control groups. Permanent CTG-monitoring was not necessary. CTG-controls after 2 and 6 hours proved to be sufficient. Uterine hyperstimulation occurred in 2.1% of cases in both groups. In every case, prompt antagonization by means of high dose betamimetic therapy could be achieved. Due to reducing maternal and foetal side effects, the maximal mobility of the mother after tablet application, as well as, for the smooth congruence of cervical ripening and labour induction, the clinical use of the 3 mg tablet is a modern alternative to the classic oxytocin induction.

Administration, Intravaginal↗
PubMed1989

[Obstetric pelvimetry using digital image intensifier radiography].

Obstetric pelvimetry can be performed by digital image intensifier radiography using very low exposure doses. Comparative measurements show a reduction of the entrance dose to 5% of conventional respectively 15% of high speed film-screen radiography. Phantom measurements have shown an accuracy of +/- 5 mm. In 30 patients the transverse diameter of the pelvic entrance, of the interspinous and of the intertuberous level as well as the sagittal diameter of the pelvic entrance and outlet were measured. Pelvimetry is indicated for the early recognition of certain risks if anamnestic (previous Caesarean section), clinical (eg. external pelvimetry) or fetometric features indicate the evidence of disproportion. As a radiological method the image intensifier radiography appears particularly recommendable in respect of its low exposure dose and the possibility of interactive measurements with subsequent documentation of the diameters and values.

Female↗
PubMed1988

[Elimination of nalbuphine in human milk].

In order to examine the pharmacokinetics and excretion of nalbuphine (Nubain 20) in breast milk, patients suffering from postpartum pain were given a single dose of 20 mg nalbuphine intramuscularly. During a 24-h period, the total amount of nalbuphine excreted in the breast milk was 2.3 micrograms (mean value), which is equivalent to 0.012% of the dosage. The mean milk/plasma quotient was calculated using the AUC from the milk and plasma time curves at 1.2:1. An oral intake of 2.3 micrograms nalbuphine would not show any measurable plasma concentrations in the neonate. Adverse opioid reactions, e.g. respiratory depression are not to be expected even if one assumes a lack of glucuronide production in the neonate.

Adult↗
PubMed1985

[Visualization of the uterine fundus in intrauterine sonography].

Intrauterine sonography (hysterosonography) is useful for visualising malignant processes in the myometrium. Since normally no sound-wave source is available for beaming the sound waves in strictly anterograde direction, the authors examined which sections of the fundus of the uterus cannot be assessed, and discussed the possibilities of reducing the area and also the importance of the inaccessible region. It was found that normally a satisfactory assessment would be possible in clinical routine even in the region of the fundus by the combined shifting of the geometrical axis of the sound waves and the use of transducers from which the sound waves emanate in anterograde direction at an angle of 135 degrees.

Female↗
PubMed1984

[The effect of the beta 1-blocker metoprolol on cyclic 3',5'-adenosine monophosphate in various tissues during long-term tocolysis with fenoterol. Animal experiments on the question of the interactive effects of the principal and adverse effects of beta 2-mimetics with special regard to fetal cardioprotection].

Using pregnant Wistar rats a comparative study was carried out, which was aimed to investigate the effect of long-term tocolysis (second half of gestation) with fenoterol alone as well as in combination with the cardioselective beta-blocker metoprolol (Beloc) upon the level of beta-adrenoceptor stimulation in maternal pulmonal, myocardial and myometrial tissue and in the myocardium of the fetuses. Radioimmunologic assessment of cyclic AMP tissue concentrations was used to obtain a parameter for beta-adrenoceptor stimulation. During treatment with fenoterol alone a significant rise of cyclic-AMP could be observed in all tissues, fetal myocardium showing the most pronounced rise. When combining fenoterol and metoprolol no derangement of the desired therapeutical beta 2-effect upon myometrium and lung could be found. Cyclic-AMP concentration in the maternal myocardium, however, was reduced significantly after combination therapy as compared to the monotherapy group, stressing the cardioprotective effect of metoprolol during beta 2-mimetic therapy, which yet has been demonstrated by means of other experimental models. As a similar tendency could be found in fetal myocardium, the conclusion may be drawn that combining metoprolol with fenoterol exerts also a fetal cardioprotection during beta 2-mimetic therapy of pregnant individuals. Furthermore possible effects of this combined therapy upon fetal beta-adrenergic reactions in general are discussed in this study.

Adrenergic beta-Agonists↗
PubMed1982

[The cardiac hazard of tocolysis and antagonising possibilities. I. The haemodynamic situation of the patient during tocolysis/Protection of the myocardium by means of cardioselective beta-blockade. Experimental results (author's transl)].

7 mongrel dogs underwent general anaesthesia and thoracotomy. For the assessment of the haemodynamic situation the following parameters were measured: Left ventricular and aortic pressure, coronary flow, oxygen-saturation in the coronary sinus, pulmonal arterial pressure, central venous pressure, heart rate. From these measurements cardiac output volume and myocardial oxygen consumption could be calculated. Using an ultrasound transit-time method regional myocardial function could be assessed. After the establishment of these measurements Fenoterol has been given in an increasing dosage up to the upper therapeutical range. Then additionally the cardioselective beta-antagonist Metoprolol was administered stepwise up to a total dose of 1.2 mg/kg body weight. The measurements proved evidence, that a relatively small dose of 0,2-0,4 mg Metoprolol/kg body weight is sufficient to compensate the haemodynamic situation impaired by Fenoterol, esp. the rise in myocardial oxygen consumption.

Animals↗
PubMed1982

[The cardiac hazard of tocolysis and antagonizing possibilities. II. Communication: protection of the myocardium by means of substitution of magnesium].

In a comparative study the value of the substitution of magnesium for the evaluation of cardiac side-effects of tocolysis has been assessed with regard to haemodynamic as well as to metabolic and morphologic alterations. Haemodynamic studies at the thoracotomized dog using the technique described in the first publication showed significantly less severe haemodynamic alterations in a group with normal magnesium blood levels than in the second group with reduced magnesium blood levels. Significant differences could be found at systolic blood pressure, cardiac output, velocity and acceleration of pressure rising, total peripherial resistance, myocardial contraction status and myocardial oxygen consumption. Likewise, a beneficial tendency could be found at the parameters: heart rate, Bretschneiders index of inotropy, pulmonal arterial pressure and coronary reserve. During chronic experiments at the rat, the addition of magnesiumaspartate led to a significantly improved preservation of high-energy phosphates in the myocardium with a concomitant reduction of lactic acid output. Also the increase of body weight was significantly higher when substituting magnesium. Microscopic examination showed no irritations of myocardial structure within the magnesium-substituted group, whereas lymphocytic infiltrations and a slight fibrosis of the endocardium could be seen at the animals having received only Fenoterol. Together, these findings lead to the conclusion, that the substitution of magnesium can act prophylactically against cardiac alterations, induced by Fenoterol. Consequently, magnesium deficiency, which frequently accompanies pregnancy, should be balanced before starting a tocolytic therapy.

Animals↗